Bulk Chemicals
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tanibirumab (CUI C3490677) Add to Cart
5/17/2018 NCI Metathesaurus Contains Exact Match Begins With Name Code Property Relationship Source ALL Advanced Search NCIm Version: 201706 Version 2.8 (using LexEVS 6.5) Home | NCIt Hierarchy | Sources | Help Suggest changes to this concept Tanibirumab (CUI C3490677) Add to Cart Table of Contents Terms & Properties Synonym Details Relationships By Source Terms & Properties Concept Unique Identifier (CUI): C3490677 NCI Thesaurus Code: C102877 (see NCI Thesaurus info) Semantic Type: Immunologic Factor Semantic Type: Amino Acid, Peptide, or Protein Semantic Type: Pharmacologic Substance NCIt Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor tyrosine kinase expressed by endothelial cells, while VEGF is overexpressed in many tumors and is correlated to tumor progression. PDQ Definition: A fully human monoclonal antibody targeting the vascular endothelial growth factor receptor 2 (VEGFR2), with potential antiangiogenic activity. Upon administration, tanibirumab specifically binds to VEGFR2, thereby preventing the binding of its ligand VEGF. This may result in the inhibition of tumor angiogenesis and a decrease in tumor nutrient supply. VEGFR2 is a pro-angiogenic growth factor receptor -
1 Abietic Acid R Abrasive Silica for Polishing DR Acenaphthene M (LC
1 abietic acid R abrasive silica for polishing DR acenaphthene M (LC) acenaphthene quinone R acenaphthylene R acetal (see 1,1-diethoxyethane) acetaldehyde M (FC) acetaldehyde-d (CH3CDO) R acetaldehyde dimethyl acetal CH acetaldoxime R acetamide M (LC) acetamidinium chloride R acetamidoacrylic acid 2- NB acetamidobenzaldehyde p- R acetamidobenzenesulfonyl chloride 4- R acetamidodeoxythioglucopyranose triacetate 2- -2- -1- -β-D- 3,4,6- AB acetamidomethylthiazole 2- -4- PB acetanilide M (LC) acetazolamide R acetdimethylamide see dimethylacetamide, N,N- acethydrazide R acetic acid M (solv) acetic anhydride M (FC) acetmethylamide see methylacetamide, N- acetoacetamide R acetoacetanilide R acetoacetic acid, lithium salt R acetobromoglucose -α-D- NB acetohydroxamic acid R acetoin R acetol (hydroxyacetone) R acetonaphthalide (α)R acetone M (solv) acetone ,A.R. M (solv) acetone-d6 RM acetone cyanohydrin R acetonedicarboxylic acid ,dimethyl ester R acetonedicarboxylic acid -1,3- R acetone dimethyl acetal see dimethoxypropane 2,2- acetonitrile M (solv) acetonitrile-d3 RM acetonylacetone see hexanedione 2,5- acetonylbenzylhydroxycoumarin (3-(α- -4- R acetophenone M (LC) acetophenone oxime R acetophenone trimethylsilyl enol ether see phenyltrimethylsilyl... acetoxyacetone (oxopropyl acetate 2-) R acetoxybenzoic acid 4- DS acetoxynaphthoic acid 6- -2- R 2 acetylacetaldehyde dimethylacetal R acetylacetone (pentanedione -2,4-) M (C) acetylbenzonitrile p- R acetylbiphenyl 4- see phenylacetophenone, p- acetyl bromide M (FC) acetylbromothiophene 2- -5- -
Wednesday May 26, 1999
5±26±99 Vol. 64 No. 101 Wednesday Pages 28333±28712 May 26, 1999 federal register 1 VerDate 06-MAY-99 21:29 May 25, 1999 Jkt 183247 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\26MYWS.XXX pfrm03 PsN: 26MYWS II Federal Register / Vol. 64, No. 101 / Wednesday, May 26, 1999 The FEDERAL REGISTER is published daily, Monday through SUBSCRIPTIONS AND COPIES Friday, except official holidays, by the Office of the Federal Register, National Archives and Records Administration, PUBLIC Washington, DC 20408, under the Federal Register Act (44 U.S.C. Subscriptions: Ch. 15) and the regulations of the Administrative Committee of Paper or fiche 202±512±1800 the Federal Register (1 CFR Ch. I). The Superintendent of Assistance with public subscriptions 512±1806 Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official edition. General online information 202±512±1530; 1±888±293±6498 Single copies/back copies: The Federal Register provides a uniform system for making available to the public regulations and legal notices issued by Paper or fiche 512±1800 Federal agencies. These include Presidential proclamations and Assistance with public single copies 512±1803 Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published Subscriptions: by act of Congress, and other Federal agency documents of public Paper or fiche 523±5243 interest. Assistance with Federal agency subscriptions 523±5243 Documents are on file for public inspection in the Office of the Federal Register the day before they are published, unless the issuing agency requests earlier filing. -
Estonian Statistics on Medicines 2016 1/41
Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole -
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG . -
Loba Chemie Pvt
TABLE OF CONTENT INTRODUCTION Contact US ii MD Letter iii Company Profile iv Latest Information v Label vi Certifications vii GMP Compliant Pharma Facility viii QC Capability ix R&D x Logistic xi COA xii SDS xiii Packing xiv Quality xvi Terms Of Sales xvii Application xviii Product Highlights xix Nanopowder & Carbon Nanotubes xxvii List of New Products xxviii ALPHABETICAL PRODUCT LISTING Price List Chemical 01-155 Ecosafe Safety Products 156-160 Macherey-Nagel Filtration Products 161-181 [email protected] I CONTACT US Contact us for more information on any of our products and services HEAD OFFICE - MUMBAI Loba Chemie Pvt. Ltd., Jehangir Villa, 107, Wode House Road, Colaba, Mumbai-400005 Maharashtra, India Tel: +91(022) 6663 6663 Fax: +91(022) 6663 6699 MANUFACTURING UNIT (TARAPUR) Loba Chemie Pvt. Ltd., Plot No.: D-22, M.I.D.C. Tarapur, Boisar, Taluka: Palghar, Thane-401506 Maharashtra, India Ph: +91(02525) 300 001 Stay up to date about our range and availability www.lobachemie.com Get in touch with us General Enquiry: [email protected] Technical Query: [email protected] Domestic Sales: [email protected] Export Sales: [email protected] Follow us on: ii www.lobachemie.com WELCOME AT LOBA CHEMIE Dear Valued Reader Another exciting year has gone by and we would like to start the New Year, as usual, with a new catalogue featuring more innova- tive highest quality range of routine and novel Laboratory Chemi- cal and Fine Reagents. With our more than 4 decads of expertise in Laboratory Chemical and Fine Reagents we not only bring you a complete Laboratory at your fingertips but in addition with our expertise we have palced our brand of products in a very competitive position for years to come. -
Alphabetical Listing of ATC Drugs & Codes
Alphabetical Listing of ATC drugs & codes. Introduction This file is an alphabetical listing of ATC codes as supplied to us in November 1999. It is supplied free as a service to those who care about good medicine use by mSupply support. To get an overview of the ATC system, use the “ATC categories.pdf” document also alvailable from www.msupply.org.nz Thanks to the WHO collaborating centre for Drug Statistics & Methodology, Norway, for supplying the raw data. I have intentionally supplied these files as PDFs so that they are not quite so easily manipulated and redistributed. I am told there is no copyright on the files, but it still seems polite to ask before using other people’s work, so please contact <[email protected]> for permission before asking us for text files. mSupply support also distributes mSupply software for inventory control, which has an inbuilt system for reporting on medicine usage using the ATC system You can download a full working version from www.msupply.org.nz Craig Drown, mSupply Support <[email protected]> April 2000 A (2-benzhydryloxyethyl)diethyl-methylammonium iodide A03AB16 0.3 g O 2-(4-chlorphenoxy)-ethanol D01AE06 4-dimethylaminophenol V03AB27 Abciximab B01AC13 25 mg P Absorbable gelatin sponge B02BC01 Acadesine C01EB13 Acamprosate V03AA03 2 g O Acarbose A10BF01 0.3 g O Acebutolol C07AB04 0.4 g O,P Acebutolol and thiazides C07BB04 Aceclidine S01EB08 Aceclidine, combinations S01EB58 Aceclofenac M01AB16 0.2 g O Acefylline piperazine R03DA09 Acemetacin M01AB11 Acenocoumarol B01AA07 5 mg O Acepromazine N05AA04 -
Otto-Catalog-2019-20.Pdf
Lab Chemicals & More..... Otto Catalog 2019-20 1 CODE PRODUCT NAME CAS NO. PACKING RATE ` PACKING RATE ` A 1214 ABSCISIC ACID practical grade 10% 14375-45-2 100mg 2007 1gm 13059 A 1215 ABSCISIC ACID for biochemistry 99% 14375-45-2 25mg 1395 100mg 3609 500 mg 17469 A 1217 (7-AMINO CEPHALOSPORANIC ACID) 7-ACA 98% 957-68-6 1gm 2403 5gm 9396 A 1225 ACACIA 9000-01-5 500gm 504 5kg 4392 A 1226 ACACIA spray dried powder 9000-01-5 500gm 684 5kg 6309 A 1227 ACACIA GR 9000-01-5 500gm 828 5kg 7407 A 0855 ACARBOSE, >95% 56180-94-0 1 gm 18099 A 1229 ACENAPHTHENE pract 83-32-9 100gm 306 500gm 1395 5 kg 11907 A 1230 ACENAPHTHENE for synthesis 97% 83-32-9 100gm 450 500gm 1692 A 1231 ACENAPHTHENE GR for HLPC 83-32-9 100gm 1359 500gm 5533 A 1234 ACES BUFFER 99% 7365-82-4 5gm 864 25gm 2385 [N-(2-Acetamido)-2-aminoethane sulfonic acid] 100 gm 8739 A 1233 ACETALDEHYDE 20-30% solution for synthesis 75-07-0 500ml 477 5lt 4095 A 1235 ACETAMIDE for synthesis 99% 60-35-5 500 gm 801 A 1240 ACETAMIDINE CHLORIDE for synthesis 124-42-5 100gm 3159 250gm 7830 A 1242 N-(2-ACETAMIDO) IMINODIACETIC ACID (ADA BUFFER) 26239-55-4 25gm 855 100gm 2592 250 gm 5994 A 1245 ACETANILIDE for synthesis 98.5% 103-84-4 500gm 918 5kg 8289 A 1248 ACETATE BUFFER SOLUTION pH 4.6 - - - - - 500ml 180 5lt 1449 A 1250 ACETIC ACID glacial 99% 64-19-7 500ml 207 5lt 1602 A 1251 ACETIC ACID glacial GR 99%+ 64-19-7 500ml 252 5lt 1908 A 1252 ACETIC ACID GLACIAL GR 99.7% 64-19-7 500ml 315 5lt 1998 A 1253 ACETIC ACID GLACIAL EL 99.9% 64-19-7 500ml 378 5lt 2502 A 1254 ACETIC ACID 99.8% for HPLC 64-19-7 -
Undergraduate Safety Manual
QUEEN’S UNIVERSITY DEPARTMENT OF CHEMISTRY UNDERGRADUATE SAFETY MANUAL Required for Use in All Undergraduate Chemistry Courses IN CASE OF EMERGENCY FROM WITHIN THE UNIVERSITY 36111 FROM OUTSIDE THE UNIVERSITY 533-6111 July 2007. i Safety in the Chemical Laboratory The following Rules have been adopted by the Department of Chemistry and apply to all undergraduate laboratories. 1. All staff and students working in laboratories share the responsibility for safety. 2. Safety goggles will be worn in all laboratories. Protective clothing will be worn as specified; open-toed shoes and sandals are not to be worn; long hair and loose clothing must be confined by net, cap or laboratory coat. Contact lenses are not recommended as they can prevent washing the eye in an emergency. 3. Horseplay, pranks and unauthorized experiments are especially dangerous and are prohibited. 4. Demonstrators shall know ahead of the laboratory period what experiments are scheduled and be cognizant of the correct working procedures. 5. No eating, drinking or smoking is permitted in any laboratory or in any other place where exposure to any toxic substance may occur by inhalation, through skin contact or by ingestion. 6. Demonstrators shall ensure that all persons using a laboratory know where the exits are, the locations of safety showers, eye-baths, and fire extinguishers, and what to do if the fire alarm sounds. 8. All supervisory personnel in a lab shall know where the nearest telephone is (emergency or open). 9. Chemicals from unlabelled containers are not to be used (except "unknowns" labeled as such and prepared for analysis or other such examples provided for some particular pedagogical purpose). -
Introduction to Fertilizers Industries
Copyright © Tarek Kakhia. All rights reserved. http://tarek.kakhia.org ADANA UNIVERSTY – INDUSTRY JOINT RESEARCH CENTER INTRODUCTIN TO FERTILIZER INDUSTRIES BY TAREK ISMAIL KAKHIA 1 Copyright © Tarek Kakhia. All rights reserved. http://tarek.kakhia.org ADANA UNIVERSTY – INDUSTRY JOINT RESEARCH CENTER page Item 3 Fertilizer 71 N - P - K rating 17 Fertilizers Inorganic Acids: 21 Sulfur 53 Sulfur Dioxide 11 Sulfur Trioxide 44 Sulfuric Acid 35 Nitrogen 35 Liquid Nitrogen 37 Nitrogen Cycle 51 Nitrogen Oxide 53 Nitric oxide ( NOX ) 22 Nitrogen Di Oxide 27 Nitrous Oxide 111 Nitric Oxide 121 Di Nitrogen Pent oxide 714 Nitric Acid 151 Phosphate Minerals ( Phosphate Rock (Phospharite ٌ 157 155 Phosphorus 132 Phosphorus Oxide 171 Phosphorus Tri Oxide 172 Phosphorus Pent Oxide 711 Phosphoric Acid 137 Phospho Gypsum 711 Fertilizers Alkalizes: 787 Ammonia 211 Ammonia Production 211 Amine Gas Treating 171 Ammonium Hydroxide 212 Category : Ammonium Compounds 221 Potassium 253 Potassium Hydroxide 211 Fertilizers Salts 215 Ammonium Ferric Citrate 2 Copyright © Tarek Kakhia. All rights reserved. http://tarek.kakhia.org ADANA UNIVERSTY – INDUSTRY JOINT RESEARCH CENTER 211 Ammonium Nitrate 215 Di Ammonium Phosphate 212 Tri Ammonium Phosphate 231 Ammonium Sulfate 232 Calcium Nitrate 231 Calcium Phosphate 233 Mono Calcium Phosphate 271 Di Calcium Phosphate 271 Tri Calcium Phosphate 271 Sodium Nitrate 267 Magnesium Phosphate 275 Di Magnesium Phosphate 272 Magnesium Sulfate 235 Potassium Chloride 235 Potassium Citrate 251 Potassium Nitrate 253 Potassium Phosphate 257 Mono Potassium Phosphate 255 Di Potassium Phosphate 252 Tri Potassium Phosphate 221 Potassium Sulfate 221 Borax 511 Organic Fertilizers: 515 Compost 513 Composting 521 Urea 555 Urea Cycle 555 Urea Phosphate 331 Extension & Supplements 511 Macronutrient & Micronutrient Fertilizers 535 Category : Phosphate minerals 533 Pozzolan 535 Pumice 5 Copyright © Tarek Kakhia. -
Estonian Statistics on Medicines 2013 1/44
Estonian Statistics on Medicines 2013 DDD/1000/ ATC code ATC group / INN (rout of admin.) Quantity sold Unit DDD Unit day A ALIMENTARY TRACT AND METABOLISM 146,8152 A01 STOMATOLOGICAL PREPARATIONS 0,0760 A01A STOMATOLOGICAL PREPARATIONS 0,0760 A01AB Antiinfectives and antiseptics for local oral treatment 0,0760 A01AB09 Miconazole(O) 7139,2 g 0,2 g 0,0760 A01AB12 Hexetidine(O) 1541120 ml A01AB81 Neomycin+Benzocaine(C) 23900 pieces A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+Thymol(dental) 2639 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+Cetylpyridinium chloride(gingival) 179340 g A01AD81 Lidocaine+Cetrimide(O) 23565 g A01AD82 Choline salicylate(O) 824240 pieces A01AD83 Lidocaine+Chamomille extract(O) 317140 g A01AD86 Lidocaine+Eugenol(gingival) 1128 g A02 DRUGS FOR ACID RELATED DISORDERS 35,6598 A02A ANTACIDS 0,9596 Combinations and complexes of aluminium, calcium and A02AD 0,9596 magnesium compounds A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 591680 pieces 10 pieces 0,1261 A02AD81 Aluminium hydroxide+Magnesium hydroxide(O) 1998558 ml 50 ml 0,0852 A02AD82 Aluminium aminoacetate+Magnesium oxide(O) 463540 pieces 10 pieces 0,0988 A02AD83 Calcium carbonate+Magnesium carbonate(O) 3049560 pieces 10 pieces 0,6497 A02AF Antacids with antiflatulents Aluminium hydroxide+Magnesium A02AF80 1000790 ml hydroxide+Simeticone(O) DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 34,7001 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 3,5364 A02BA02 Ranitidine(O) 494352,3 g 0,3 g 3,5106 A02BA02 Ranitidine(P) -
Phase of Atmospheric Secondary Organic Material Affects Its Reactivity
Phase of atmospheric secondary organic material affects its reactivity Mikinori Kuwata and Scot T. Martin1 School of Engineering and Applied Sciences and Department of Earth and Planetary Sciences, Harvard University, Cambridge, MA 02138 Edited by Mark H. Thiemens, University of California San Diego, La Jolla, CA, and approved September 11, 2012 (received for review May 29, 2012) The interconversion of atmospheric organic particles among solid, The atmospheric occurrence of organic semisolid particles can semisolid, and liquid phases is of keen current scientific interest, have important implications for aging processes. Aging can sig- especially for particles of secondary organic material (SOM). Here- nificantly alter a particle’s physicochemical properties, including in, the influence of phase on ammonia uptake and subsequent hygroscopic and optical properties (1). Diffusion of molecules particle-phase reactions was investigated for aerosol particles of in a semisolid, however, is much slower than in a liquid. The adipic acid and α-pinene ozonolysis SOM. The nitrogen content Stokes–Einstein equation states that the diffusion coefficient D of the particles was monitored by online mass spectrometry for is proportional to η−1 (12). The timescale for homogeneous mix- increasing ammonia exposure. Solid and semisolid adipic acid ing by diffusion is on the order of microseconds to milliseconds particles were inert to the ammonia uptake for low RH (<5%). for liquid submicron particles. By comparison, for semisolid par- For the solid particles, ammonia exposure at high relative humidity ticles the timescale can range from seconds to days, depending on (RH; >94%) induced a first-order deliquescence phase transition the viscosity of particles (16).